Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Eclipsing Toxicity, Enhancing Efficacy: Clofazimine's Van... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Eclipsing Toxicity, Enhancing Efficacy: Clofazimine's Vanguard in the Realm of anti-PD-1 and CTLA-4 Immunotherapy
0
Authors
Ruirong Tan
2 more
Ruirong Tan
•
Junning Zhao
•
Quazi Shubhra
Published
January 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Research
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Vanguard
Show all topics
DOI
10.34133/research.0419
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Research
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Vanguard
Show all topics
DOI
10.34133/research.0419
License
CC-BY
